@article{94338,
  keywords = {Neglected tropical diseases (NTDs), diagnosis, Covid-19},
  author = {de Souza D and Picado A and Biéler S and Nogaro S and Ndung'u JM},
  title = {Diagnosis of neglected tropical diseases during and after the COVID-19 pandemic.},
  abstract = {The occurrence of coronavirus disease 2019 (COVID-19) causing severe pneumonia and death was first reported in December 2019 in Wuhan, China. This was subsequently revealed to be similar to severe acute respiratory syndrome coronavirus and named SARS-CoV-2 [1]. Since December 2019, more than 20.6 million cases have been reported, with over 749,000 deaths [2]. The urgent need to develop diagnostics for COVID-19 has resulted in the already under-resourced development and manufacturing of rapid diagnostic tests (RDTs) and molecular tests for many tropical diseases being placed on hold. In this article, we assess the impact that COVID-19, and the strategies put in place to control the pandemic, may have on neglected tropical diseases (NTDs), and in particular on the diagnostic capacity and needs of those diseases.},
  year = {2020},
  journal = {PLoS neglected tropical diseases},
  volume = {14},
  pages = {e0008587},
  month = {01/2020},
  issn = {1935-2735},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428349/pdf/pntd.0008587.pdf},
  doi = {10.1371/journal.pntd.0008587},
  language = {eng},
}